Literature DB >> 25070588

Severe cutaneous adverse reactions in a local hospital setting: a 5-year retrospective study.

Peiqi Su1, Chen Wee Derrick Aw.   

Abstract

BACKGROUND: Severe cutaneous adverse reactions (SCAR) are rare but important causes of morbidity and mortality. Stevens-Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS) are severe cutaneous drug reactions that can be potentially life threatening. Our study aims to look at the epidemiology of SCAR in the local setting in Singapore and the underlying characteristics of our patients that may influence the drug reaction seen.
METHODS: Data was collected retrospectively from in-patient records in the period of January 2007 to December 2011. We looked at several factors: (i) patient demographics including age, gender, ethnicity, comorbidities, (ii) culprit drug(s), (iii) latent period, (iv) drug reaction observed, (v) systemic complications, (vi) length of hospital stay, (vii) treatment given, and (viii) outcomes (mortality, morbidity).
RESULTS: We collected data from 42 patients. The mean age of our patients was 51.8 years. Twenty-nine (69%) of the patients had underlying comorbidities. The most common culprit drug group was antibiotics. SJS was the most common SCAR observed (54.8%), followed by acute generalized exanthematous pustolosis (AGEP; 24%), TEN (11.9%), and DRESS (2%). Sixteen patients (38.1%) had complications, and there was one reported death. There was a weak correlation (correlation coefficient 0.29, P value = 0.15, 95% CI = 2.07) between early steroid therapy and the length of stay.
CONCLUSIONS: Antibiotics are the most common culprit drugs. The most common SCAR observed in our study was SJS. Early initiation of steroids may lead to a more favorable outcome.
© 2014 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25070588     DOI: 10.1111/ijd.12118

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  13 in total

1.  Severe cutaneous adverse drug reactions of Chinese inpatients: a meta-analysis.

Authors:  Qiancheng Deng; Xia Fang; Qinghai Zeng; Jianyun Lu; Chen Jing; Jinhua Huang
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

Review 2.  Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis.

Authors:  Stefanie Zimmermann; Peggy Sekula; Moritz Venhoff; Edith Motschall; Jochen Knaus; Martin Schumacher; Maja Mockenhaupt
Journal:  JAMA Dermatol       Date:  2017-06-01       Impact factor: 10.282

3.  Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.

Authors:  Leelawadee Techasatian; Sunee Panombualert; Rattapon Uppala; Charoon Jetsrisuparb
Journal:  World J Pediatr       Date:  2016-09-20       Impact factor: 2.764

4.  More than skin deep. Ten year follow-up of delayed cutaneous adverse drug reactions (CADR).

Authors:  Linda Velta Graudins; Jenny Ly; Jason Trubiano; Ar Kar Aung
Journal:  Br J Clin Pharmacol       Date:  2016-07-18       Impact factor: 4.335

Review 5.  Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.

Authors:  Jonathan Grant Peter; Rannakoe Lehloenya; Sipho Dlamini; Kimberly Risma; Katie D White; Katherine C Konvinse; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun

6.  Fluoroquinolone-related adverse events resulting in health service use and costs: A systematic review.

Authors:  Laura S M Kuula; Kati M Viljemaa; Janne T Backman; Marja Blom
Journal:  PLoS One       Date:  2019-04-26       Impact factor: 3.240

7.  Healthcare costs and mortality associated with serious fluoroquinolone-related adverse reactions.

Authors:  Laura S M Kuula; Janne T Backman; Marja L Blom
Journal:  Pharmacol Res Perspect       Date:  2022-04

Review 8.  Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions.

Authors:  Jason H Karnes; Matthew A Miller; Katie D White; Katherine C Konvinse; Rebecca K Pavlos; Alec J Redwood; Jonathan G Peter; Rannakoe Lehloenya; Simon A Mallal; Elizabeth J Phillips
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-08-22       Impact factor: 13.820

9.  The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China.

Authors:  Shang-Chen Yang; Sindy Hu; Sheng-Zheng Zhang; Jin-Wen Huang; Jing Zhang; Chao Ji; Bo Cheng
Journal:  J Immunol Res       Date:  2018-02-11       Impact factor: 4.818

Review 10.  Drug hypersensitivity reactions in Asia: regional issues and challenges.

Authors:  Bernard Yu-Hor Thong; Michaela Lucas; Hye-Ryun Kang; Yoon-Seok Chang; Philip Hei Li; Min Moon Tang; James Yun; Jie Shen Fok; Byung-Keun Kim; Mizuho Nagao; Iris Rengganis; Yi-Giien Tsai; Wen-Hung Chung; Masao Yamaguchi; Ticha Rerkpattanapipat; Wasu Kamchaisatian; Ting Fan Leung; Ho Joo Yoon; Luo Zhang; Amir Hamzah Abdul Latiff; Takao Fujisawa; Francis Thien; Mariana C Castells; Pascal Demoly; Jiu-Yao Wang; Ruby Pawankar
Journal:  Asia Pac Allergy       Date:  2020-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.